Open Access Open Access  Restricted Access Subscription or Fee Access
coumarin alzeheimer disease

Design, synthesis and evaluation of Coumarin-Phenylthiazole conjugates as cholinesterase inhibitors

Deepak Mishra, Atiya Fatima, Ram Singh, Nupur S Munjal, Vineet Mehta, Udayabanu Malairaman


In this paper we report the design, synthesis, in-silico and in-vitro evaluations of a series of coumarin-phenylthiazole conjugates to inhibit cholinesterase enzymes. The coumarin and phenylthiazole derivatives were synthesized separately and further combined through covalent amine bond linkage. The compounds showed more inhibition towards BuChE than AChE. The compound, 4-(3-bromophenyl)-1,3-thiazol-2-amine exhibited the strongest inhibition against BuChE with an IC50 value of 3.54 μM. For the conjugates, better inhibition activities towards BuChE are shown by 3-nitro, 3-bromo and 2-fluoro derivatives. It was also observed that the substitution at 3-position, on phenylthiazole produced better results against BuChE than 4-substituted counterparts.


Coumarin; Phenylthiazole; AChE; BuChE; Alzheimer’s disease;

Full Text:


ISSN 2347–9825

Open Access: Any researcher from India and other developing/low economy countries (provided freedly through WHO-HINARI) can seek any published CBL article for their persoanl use at free of cost. Write with article title to editorial office (contact us page).